Efaproxiral is a synthetic allosteric modifier of hemoglobin that functions as a radiosensitizer by decreasing oxygen-binding affinity, thereby facilitating oxygen release into hypoxic tumor tissues during… Read more
Efaproxiral is a synthetic allosteric modifier of hemoglobin that functions as a radiosensitizer by decreasing oxygen-binding affinity, thereby facilitating oxygen release into hypoxic tumor tissues during radiation therapy. This category provides essential pharmaceutical reference standards, including the parent drug, its associated impurities, and stable isotope labelled compounds such as Efaproxiral-d6. These materials are critical for rigorous quality control and pharmaceutical research. Laboratories utilize these high-quality compounds for precise impurity profiling, ensuring consistency in analytical testing and compliance with regulatory requirements. Furthermore, stable isotope labelled compounds serve as vital internal standards in liquid chromatography-mass spectrometry (LC-MS) and other analytical workflows, enabling accurate quantification and the validation of analytical methods during pharmacokinetic studies. By providing reliable reference materials, these compounds support the comprehensive assessment of the drug substance and its metabolic pathways throughout the development process.